PROTOCOL 3: Role of the Renal Nerves in the Increase in EGP in Response to Glucosuria

NCT03168295 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

34

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Dapagliflozin 10mg then Placebo Oral Tablet
DRUG: Placebo Oral Tablet then Dapagliflozin 10mg

Sponsor

The University of Texas Health Science Center at San Antonio

Collaborators

[object Object]
[object Object]